Project

Real world utilization of upadacitinib in adult and adolescent patients living with moderate to severe atopic dermatitis (AD-VISE)

Ongoing - recruitment active ยท 2022 until 2025

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2022
End Date
2025
Financing
Industry
Phase
IV
Brief description/objective